Vitamin B12 status of infants aged 4–12 months with neurodevelopmental abnormalities without any obvious cause and their outcome at 6 months after treatment: A prospective pilot cohort study
Kumaresan Gokulpriya, Dhandapany Gunasekaran, Sharbari Basu, Nivedita MondalBackground
Developmental disabilities affect millions of children globally, and vitamin B12 deficiency is a potential cause, particularly in Indian infants.
Aim
This prospective pilot cohort study evaluated vitamin B12 status in infants with neurodevelopmental abnormalities and feeding difficulties and assessed the impact of B12 treatment on their developmental outcomes.
Methods
Forty infants aged 4–12 months with neurodevelopmental disabilities or feeding difficulties without an obvious cause from the history and clinical examination were enrolled. Infants were divided into two groups based on their serum vitamin B12 levels: deficient and sufficient. All infants received supportive therapy (early stimulation, nutritional counseling, and physiotherapy). Additionally, infants with vitamin B12 deficiency received B12 treatment. Improvements in clinical features, anthropometric status, and developmental scores (using the Developmental Assessment Scale for Indian Infants) were assessed at baseline and after 6 months and compared within the groups.
Summary
Vitamin B12 deficiency was found in 62.5% (